ReiThera is a biotech company with a long-standing expertise in the development of scalable processes for viral vector manufacturing and has a consolidated experience in the GMP production of Adeno Viral vector (AdV), Adeno Associated Vector (AAVx), Lentivirus (LV), MVA, HSV and other.

ReiThera bases its core manufacturing capacity in a state-of-the-art facility including stirred-tank bioreactors at the scale of 50L, 200L, 1000L and 2000L and fixed bed bioreactors for cell growth in adherence. The GMP facility is inclusive of filling suite and quality control laboratories.

In addition, ReiThera has a consolidated experience in immunology and in the set-up of immuno-profiling studies focused in the monitoring of the immune responses to pathogens, vaccines, gene-therapy and immunotherapeutics during preclinical and clinical trials.